Armata Pharmaceuticals stock price
아마타 파머슈티컬스NYSEAMERICAN:ARMP · NYSE Amex · HealthcareToday's signals · No active technical signal.
Signal details →Armata Pharmaceuticals last closed at $3.52 (+6.34%) on 2026-10-02. Listed on NYSE Amex. Trailing 12 months PER is -1.1×. Its overall grade ranks 188 of 739 stocks in Healthcare.
About this company
Armata Pharmaceuticals last closed at $3.52 (+6.34%) on 2026-10-02. Listed on NYSE Amex.
Details →Reported results
Position in sector
Healthcare · Overall A- · 188/739
Valuation grade A-
Related stocks
- AstraZenecaCustomer
호흡기·감염병 후보물질의 잠재 파트너/라이선스 고객 가능성이 큼
- PfizerCustomer
항생제·감염질환 신약의 잠재적 상업화 파트너
- GSKCustomer
감염병 포트폴리오 협력 및 라이선스 아웃 가능성이 있는 대형 제약사
About Armata Pharmaceuticals
- What technical signals does Armata Pharmaceuticals (ARMP) have?
- Armata Pharmaceuticals current technical signals: no active technical signal.
- Is Armata Pharmaceuticals a cup-and-handle pattern?
- No. Armata Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Armata Pharmaceuticals?
- Market cap: $128.15M. Trailing 12 months PER: -1.1×. Latest quarter PBR: -0.94×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about Armata Pharmaceuticals, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).